Radar›Companies›Finance Services Stocks in USA: Revenue Cohort 4
United States finance services industry landscape illustrating listed-company operations, infrastructure and market activity
Prism Finance USA · comparison snapshot

Finance Services Stocks in USA: Revenue Cohort 4

A five-company finance services cohort selected by latest filing revenue, then compared across market path, filings, profitability, readiness, Prism attention and industry context.

Snapshot: 31 August 2026Not investment adviceRanked by Prism readiness
Readiness leaderTeraWulf · 53
Strongest available pathTeraWulf · -46.7%
Widest latest marginQualigen · -374.0%
Companies compared5 · U.S.-listed
01 · Readiness ranking

Five companies, one comparable score

Companies are ordered by the Fliar BI Prism readiness score used by the Prism Finance USA source pack. The score is a research signal, not a recommendation.

Readiness #1WULF · Nasdaq

TeraWulf

A U.S.-listed issuer classified by the SEC in Finance Services

Founded 2021Easton, Maryland$7.55B market cap
View full Companies Radar profile
53Moderate
Snapshot price$15.13as of page date
Monthly-close return-46.7%five-year window
FY2025 revenue$0.15BTERAWULF INC.
Net margin-444.8%FY2025
P/E snapshot-63.0xone ratio, not a verdict
Prism attention1.1%share across these five
Filing track recordRevenue, USD billions
+744.0%
$0$0.0B$0.1B$0.1BFY2019: $0.018BFY2020: $0.013BFY2022: $0.015BFY2023: $0.069BFY2025: $0.149B20192020202220232025
FY2019–FY2025 · 5 filing periods · TOTAL REVENUE · Revenue derived as cost of revenue plus gross profit for FY2022, FY2023, FY2025 · CAGR 70.4%
52-week position31% through range
$8.60$29.84
News mentions2.7K
Community mentions0partial coverage
U.S.-scope patents0
Prism Insights

What sits behind the readiness signal

Observed risk 4/100higher means more observed risk
Earnings signal32/100
Management stability90/100
Market position61/100
Capital-event signal100/100
Innovation pulse5/100
Management signal

No leadership-churn flag in the model; 0 key-person events recorded in the latest 360-day window.

Market activity

Available history contains 4 M&A involvements, 21 asset-acquisition events and 21 contract events.

Innovation activity

Prism records 0 lifetime product-launch events, 0 in the latest 360 days, and 2 company announcements in that window.

Recent risk watch

Recent available records contain 0 lawsuit, 1 regulatory and 0 layoff events across their stated windows.

Prism model components and available company-event evidence; scores are research signals, not recommendations. Event totals describe available coverage and may not be exhaustive.

Readiness #2TONX · Nasdaq

Verb Technology

A U.S.-listed issuer classified by the SEC in Finance Services

Founded 2012Carson City$187.2M market cap
View full Companies Radar profile
46Cautious
Snapshot price$3.40as of page date
Monthly-close return-100.0%five-year window
FY2025 revenue$0.01BTON Strategy Co
Net margin-1161.9%FY2025
Prism attention0.2%share across these five
Filing track recordRevenue, USD billions
+21.4%
$0$0.0B$0.0B$0.0BFY2021: $0.011BFY2022: $0.009BFY2023: $0.000BFY2024: $0.001BFY2025: $0.013B20212022202320242025
FY2021–FY2025 · 5 filing periods · TOTAL REVENUE · Normalized revenue metric from the in-house filings extraction · CAGR 5.0%
52-week position14% through range
$1.75$13.90
News mentions377
Community mentions0partial coverage
U.S.-scope patents0
Prism Insights

What sits behind the readiness signal

Observed risk 0/100higher means more observed risk
Earnings signal70/100
Management stability90/100
Market position4/100
Capital-event signal40/100
Innovation pulse0/100
Management signal

No leadership-churn flag in the model; 0 key-person events recorded in the latest 360-day window.

Market activity

Available history contains 0 M&A involvements, 2 asset-acquisition events and 1 contract events.

Innovation activity

Prism records 27 lifetime product-launch events, 0 in the latest 360 days, and 0 company announcements in that window.

Recent risk watch

No lawsuit or regulatory event is recorded in the latest 360-day window and no layoff event in the latest 180-day window. This is not legal clearance.

Prism model components and available company-event evidence; scores are research signals, not recommendations. Event totals describe available coverage and may not be exhaustive.

Readiness #3NCPL · NASDAQ

NetCapital Systems

A U.S.-listed issuer classified by the SEC in Finance Services

Founded 2014Boston, Massachusetts$5.6M market cap
View full Companies Radar profile
43Cautious
Snapshot price$0.72as of page date
Monthly-close return-99.9%five-year window
FY2025 revenue$0.00BNetcapital Inc.
Net margin-3255.0%FY2025
Prism attention0.1%share across these five
Filing track recordRevenue, USD billions
-81.6%
$0$0.0B$0.0B$0.0BFY2021: $0.005BFY2022: $0.005BFY2023: $0.008BFY2024: $0.005BFY2025: $0.001B20212022202320242025
FY2021–FY2025 · 5 filing periods · TOTAL REVENUE · Revenue derived as cost of revenue plus gross profit for FY2021, FY2022, FY2023 · CAGR -34.5%
52-week position20% through range
$0.21$2.75
News mentions336
Community mentions0partial coverage
U.S.-scope patents0
Prism Insights

What sits behind the readiness signal

Observed risk 0/100higher means more observed risk
Earnings signal45/100
Management stability90/100
Market position4/100
Capital-event signal67/100
Innovation pulse0/100
Management signal

No leadership-churn flag in the model; 2 key-person events recorded in the latest 360-day window.

Market activity

Available history contains 0 M&A involvements, 2 asset-acquisition events and 0 contract events.

Innovation activity

Prism records 2 lifetime product-launch events, 0 in the latest 360 days, and 0 company announcements in that window.

Recent risk watch

No lawsuit or regulatory event is recorded in the latest 360-day window and no layoff event in the latest 180-day window. This is not legal clearance.

Prism model components and available company-event evidence; scores are research signals, not recommendations. Event totals describe available coverage and may not be exhaustive.

Readiness #4HSDT · Nasdaq

Helius Medical

A U.S.-listed issuer classified by the SEC in Finance Services

Founded 2021Solana Beach, California$133.6M market cap
View full Companies Radar profile
42Cautious
Snapshot price$2.21as of page date
Monthly-close return-100.0%five-year window
FY2025 revenue$0.00BSolana Co
Net margin-7461.7%FY2025
P/E snapshot0.0xone ratio, not a verdict
Prism attention98.4%share across these five
Filing track recordRevenue, USD billions
+5.0%
$0$0.0B$0.0B$0.0BFY2021: $0.001BFY2022: $0.001BFY2023: $0.001BFY2024: $0.000BFY2025: $0.001B20212022202320242025
FY2021–FY2025 · 5 filing periods · TOTAL REVENUE · Normalized revenue metric from the in-house filings extraction · CAGR 1.2%
52-week position4% through range
$1.19$25.50
News mentions237.7K
Community mentions0partial coverage
U.S.-scope patents39
Prism Insights

What sits behind the readiness signal

Observed risk 0/100higher means more observed risk
Earnings signal21/100
Management stability90/100
Market position13/100
Capital-event signal93/100
Innovation pulse0/100
Management signal

No leadership-churn flag in the model; 0 key-person events recorded in the latest 360-day window.

Market activity

Available history contains 1 M&A involvements, 1 asset-acquisition events and 2 contract events.

Innovation activity

Prism records 0 lifetime product-launch events, 0 in the latest 360 days, and 0 company announcements in that window.

Recent risk watch

No lawsuit or regulatory event is recorded in the latest 360-day window and no layoff event in the latest 180-day window. This is not legal clearance.

Prism model components and available company-event evidence; scores are research signals, not recommendations. Event totals describe available coverage and may not be exhaustive.

Readiness #5AIXC · Nasdaq

Qualigen

A U.S.-listed issuer classified by the SEC in Finance Services

Founded 2004Carlsbad$16.5M market cap
View full Companies Radar profile
34Cautious
Snapshot price$0.81as of page date
Monthly-close return-99.9%five-year window
FY2022 revenue$0.01BAIxCrypto Holdings, Inc.
Net margin-374.0%FY2022
Prism attention0.2%share across these five
Filing track recordRevenue, USD billions
-11.9%
$0$0.0B$0.0B$0.0BFY2021: $0.006BFY2022: $0.005B20212022
FY2021–FY2022 · 2 filing periods · TOTAL REVENUE · Normalized revenue metric from the in-house filings extraction · CAGR -11.9%
52-week position3% through range
$0.59$8.81
News mentions500
Community mentions0partial coverage
U.S.-scope patents94
Prism Insights

What sits behind the readiness signal

Observed risk 4/100higher means more observed risk
Earnings signal62/100
Management stability55/100
Market position10/100
Capital-event signal25/100
Innovation pulse0/100
Management signal

Leadership churn is flagged elevated; 9 key-person events were recorded in the latest 360-day window.

Market activity

Available history contains 7 M&A involvements, 0 asset-acquisition events and 2 contract events.

Innovation activity

Prism records 0 lifetime product-launch events, 0 in the latest 360 days, and 0 company announcements in that window.

Recent risk watch

Recent available records contain 0 lawsuit, 1 regulatory and 0 layoff events across their stated windows.

Prism model components and available company-event evidence; scores are research signals, not recommendations. Event totals describe available coverage and may not be exhaustive.

02 · Side-by-side

The comparisons that change the picture

Every bar preserves its own meaning. Price return, revenue scale, profitability and attention are deliberately not blended into one recommendation.

Available monthly-close return

Dated window printed on each company card; not a forecast.

TeraWulf
-46.7%
NetCapital Systems
-99.9%
Qualigen
-99.9%
Verb Technology
-100.0%
Helius Medical
-100.0%

Latest revenue

USD billions, official filing scope shown on each company card.

TeraWulf
$0.15B
Verb Technology
$0.01B
Qualigen
$0.01B
NetCapital Systems
$0.00B
Helius Medical
$0.00B

Latest profit margin

Company-card labels distinguish continuing-operations and net-income scope.

Qualigen
-374.0%
TeraWulf
-444.8%
Verb Technology
-1161.9%
NetCapital Systems
-3255.0%
Helius Medical
-7461.7%

Prism news attention

Normalized share across these five names; attention is not quality.

Helius Medical
98.4%
TeraWulf
1.1%
Verb Technology
0.2%
Qualigen
0.2%
NetCapital Systems
0.1%
03 · Prism readout

What the signals say—and what they do not

The headline share is normalized finance services news attention across these five names. Partial community coverage and U.S.-scope patent records are displayed separately and are not blended into it.

Scale + attention

Helius Medical leads the conversation

It holds 98.4% of measured finance services news attention and also carries the basket's largest revenue base at $0.00B.

Price path

TeraWulf leads the available price paths

Its monthly-close return is -46.7% for the five-year window. At the other end, Verb Technology is -100.0% for its five-year window. Windows printed on each card must be compared carefully; price history is not a forecast.

Profitability

Qualigen has the widest latest margin

Its FY2022 net margin is -374.0%. Its revenue history in this snapshot spans only the periods printed on its card, so longer histories are not treated as equivalent.

Price vs operating signals

TeraWulf shows why one ratio is not a verdict

It has the basket's lowest snapshot P/E at -63.0x while its five-year window price return is -46.7%. Valuation, price path and readiness answer different questions.

04 · Research areas

Deeper Prism readout where coverage is dense

Shown only for companies with more than 800 available Prism news records. Counts describe the available research corpus, not company quality.

Areas of research · WULF

TeraWulf

2,661available Prism news records

Prism top themes

Price action & investor response
234
Earnings & financial performance
131
Legal, arbitration & regulatory
67
Macro demand & rates
64
Capital allocation & transactions
59

Mapped subcategory tag occurrences; one article may contribute more than one tag. Since 2024-01-01.

News-volume growth

+63.7%1,123 latest 12m vs 686 prior 12m
2024-03: 33 mentions2024-04: 32 mentions2024-05: 42 mentions2024-06: 39 mentions2024-07: 28 mentions2024-08: 63 mentions2024-09: 59 mentions2024-10: 91 mentions2024-11: 44 mentions2024-12: 55 mentions2025-01: 66 mentions2025-02: 49 mentions2025-03: 34 mentions2025-04: 48 mentions2025-05: 37 mentions2025-06: 37 mentions2025-07: 21 mentions2025-08: 145 mentions2025-09: 102 mentions2025-10: 146 mentions2025-11: 146 mentions2025-12: 107 mentions2026-01: 64 mentions2026-02: 170 mentions2026-03: 85 mentions2026-04: 144 mentions2026-05: 134 mentions2026-06: 23 mentions2026-07: 1 mentions2026-08: 1 mentions2024-032026-08

Machine-classified coverage tone

80.5% positive+0.3 pp vs preceding four quarters
24Q4
25Q1
25Q2
25Q3
25Q4
26Q1
26Q2
26Q3

Tone of available coverage, not business performance or an investment outlook.

Frequent keywords

stock price 59stock performance 41bitcoin price 33share price 32invesco currency etfs 29stablecoin fx impact 29currency etfs 28earnings report 24

Keyword tag occurrences in available Prism news records.

Coverage: 2011-05-02–2026-08-03 · trend and themes shown through 2026-08
Areas of research · HSDT

Helius Medical

237,703available Prism news records

Prism top themes

Macro demand & rates
6,226
Legal, arbitration & regulatory
3,775
Price action & investor response
2,168
Capital allocation & transactions
366
Earnings & financial performance
145

Mapped subcategory tag occurrences; one article may contribute more than one tag. Since 2024-01-01.

News-volume growth

-41.2%56,011 latest 12m vs 95,253 prior 12m
2024-03: 2,554 mentions2024-04: 2,677 mentions2024-05: 2,621 mentions2024-06: 2,477 mentions2024-07: 2,608 mentions2024-08: 4,865 mentions2024-09: 6,188 mentions2024-10: 7,230 mentions2024-11: 8,496 mentions2024-12: 9,737 mentions2025-01: 10,671 mentions2025-02: 9,694 mentions2025-03: 8,656 mentions2025-04: 8,632 mentions2025-05: 8,396 mentions2025-06: 7,419 mentions2025-07: 5,131 mentions2025-08: 5,003 mentions2025-09: 7,101 mentions2025-10: 7,761 mentions2025-11: 6,846 mentions2025-12: 6,222 mentions2026-01: 4,201 mentions2026-02: 5,675 mentions2026-03: 4,880 mentions2026-04: 8,043 mentions2026-05: 4,501 mentions2026-06: 776 mentions2026-07: 4 mentions2026-08: 1 mentions2024-032026-08

Machine-classified coverage tone

76.1% positive-6.6 pp vs preceding four quarters
24Q4
25Q1
25Q2
25Q3
25Q4
26Q1
26Q2
26Q3

Tone of available coverage, not business performance or an investment outlook.

Frequent keywords

stablecoin fx impact 9,561decentralized forex 8,769invesco currency etfs 6,038currency etfs 5,988currency basket etfs 4,643fx etfs 4,504leveraged fx etfs 3,635crypto-fiat arbitrage 3,619

Keyword tag occurrences in available Prism news records.

Coverage: 2010-01-07–2026-08-04 · trend and themes shown through 2026-08
05 · Community discussion

Common topics where conversation clears the gate

Shown only above 25 entity-matched mentions. Coverage is partial and topic counts exclude identified namesake noise.

06 · Company event log

Common news types and recent highlights

Event patterns and selected recent headlines come from available Prism company-event records since 2023. Obvious forecast, holdings, duplicate and retrospective noise is filtered.

WULF

TeraWulf

through 2026-04-14
Earnings releases 43Company announcements 35Asset acquisitions 18Business contracts 18Lawsuits 5
  1. Earnings releases

    "The Company expects first quarter 2026 revenue to be between $30 million and $35 million, and adjusted EBITDA to be between $0 million and $3 million."

  2. Regulatory

    The Federal Energy Regulatory Commission should reject TeraWulf’s planned power plant purchase in Maryland because the seller failed to disclose Google’s 14% ownership stake in the data center company, Public Citizen and other groups said.

  3. Business contracts

    Fluor Corporation (NYSE: FLR ) announced today that its Advanced Technologies business has signed a limited notice to proceed (LNTP) with TeraWulf Inc. The agreement covers master planning and pre‑construction services for a large‑scale brownfield data center campus in North Central Kentucky with access of up to 480 megawatts of grid‑connected power.

Prism company-event records; exact duplicates and evident forecast, holdings and retrospective noise are excluded.

TONX

Verb Technology

through 2025-05-09
Earnings releases 6Company announcements 5Asset acquisitions 2Listing / IPO 2
  1. Earnings releases

    Verb Technology Company, Inc. (Nasdaq: VERB) ("VERB" or the "Company"), Transforming the Landscape of Social Commerce, Social Telehealth and Social Crowdfunding with MARKET.live; VANITYPrescribed; GoodGirlRx; and the GO FUND YOURSELF TV Show , today announced that VERB CEO Rory J. Cutaia will host a conference call to discuss the Company’s financial results for the first quarter 2025 on Tuesday, May 13, 2025, at 1:00 p.m. Eastern time (10:00 a.m. Pacific time).

  2. Company announcements

    Balance Sheet Enhancement: In the past 6 months, we paid-down approximately $5.5 million in debt, representing a 66% reduction.

  3. Asset acquisitions

    the Company executed an asset purchase agreement with Scaleworks, Inc., a San Antonio, TX-based B2B software private equity fund, through its special purpose entity SW Direct Sales, LLC and simultaneously closed the sale of all assets that comprised its direct sales and life sciences software-as-a-service applications

Prism company-event records; exact duplicates and evident forecast, holdings and retrospective noise are excluded.

NCPL

NetCapital Systems

through 2026-04-18
Earnings releases 15Leadership changes 4Asset acquisitions 2Listing / IPO 2
  1. Earnings releases

    Netcapital $870,000.00 3.79 -$28.30 million ($15.49) -0.03

  2. Leadership changes

    Netcapital Inc., a publicly traded fintech company that gives companies access to capital markets infrastructure without institutional scale fees, announced that its Board of Directors has appointed Mr. Violette to lead the Company.

  3. Asset acquisitions

    Netcapital Inc. (NASDAQ: NCPL, NCPLW), a digital private capital markets ecosystem, announced the acquisition of the assets of Iverson Design, LLC, a creative studio and developer of AI-powered design and visualization tools.

Prism company-event records; exact duplicates and evident forecast, holdings and retrospective noise are excluded.

HSDT

Helius Medical

through 2025-09-24
Earnings releases 9Asset acquisitions 1Business contracts 1Company announcements 1Listing / IPO 1
  1. Asset acquisitions

    Pantera-backed Helius Medical Technologies has purchased its first Solana tokens, marking the start of a corporate treasury reserve built around the sixth-largest cryptocurrency by market capitalization.

  2. Business contracts

    On September 15, 2025, Helius Medical Technologies, Inc. entered into a Sales Agreement with Clear Street LLC and Maxim Group LLC to offer and sell shares of its Class A common stock, with a potential aggregate sales price of up to $92.8 million.

  3. Earnings releases

    In its latest earnings report for the quarter ending June 30, 2025, Helius Medical Technologies Inc. highlighted a significant increase in cash and cash equivalents, rising to $6.1 million from $1.1 million at the end of 2024, despite facing a net loss of $9.8 million for the quarter.

Prism company-event records; exact duplicates and evident forecast, holdings and retrospective noise are excluded.

AIXC

Qualigen

through 2025-11-16
Leadership changes 9Company announcements 3M&A 1Regulatory 1
  1. Regulatory

    Subscription Agreement Approval under Nasdaq Rules 5635(a) and 5635(b), authorizing issuance of 337,432 common shares and 39,943 Series B convertible preferred shares.

  2. Leadership changes

    Effective October 2, 2025, Jerry (Jiawei) Wang was appointed as Co-Chief Executive Officer, and Koti Meka was appointed as Chief Financial Officer of Qualigen Therapeutics.

  3. M&A

    Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced today they have entered a non‑binding Memorandum of Understanding (MOU) to acquire Marizyme (OTC: MRZM).

Prism company-event records; exact duplicates and evident forecast, holdings and retrospective noise are excluded.

07 · Industry landscape

Finance Services Industry in USA

A bottom-of-page sector lens combining Prism's exact U.S. market-growth extraction with tightly matched U.S.-primary finance services news. It adds context to the stock basket without turning industry signals into a recommendation.

Prism market forecast extraction

fintech market

14 sources73.9% extraction confidence
2025 extracted base$58.01B–$142.50B
2034 extracted forecast$461.57B–$595.00B
Implied source CAGR17.2%
financial servicesOEM-Pay solutionsApple Pay

Multi-source card returned by Prism's /special_extraction market-growth service. Extracted geography mix: Global, Australia, India, Europe. This is a dated market benchmark, not a forecast for the five-stock basket.

Prism news insights

U.S. Finance Services news pulse

51,447available Prism news records
Latest 12m volume+10.7%22916 vs 20708 records
Positive classified tone61.4%+15.8 pp vs prior four quarters
2024-01: 1,353 mentions2024-02: 1,540 mentions2024-03: 1,773 mentions2024-04: 1,497 mentions2024-05: 1,660 mentions2024-06: 1,341 mentions2024-07: 1,637 mentions2024-08: 1,565 mentions2024-09: 1,491 mentions2024-10: 2,280 mentions2024-11: 2,039 mentions2024-12: 1,257 mentions2025-01: 1,522 mentions2025-02: 1,471 mentions2025-03: 1,834 mentions2025-04: 2,369 mentions2025-05: 1,902 mentions2025-06: 1,125 mentions2025-07: 2,677 mentions2025-08: 5,171 mentions2025-09: 1,789 mentions2025-10: 1,562 mentions2025-11: 1,365 mentions2025-12: 1,656 mentions2026-01: 926 mentions2026-02: 2,083 mentions2026-03: 1,790 mentions2026-04: 2,564 mentions2026-05: 208 mentions2024-012026-05
24Q4
25Q1
25Q2
25Q3
25Q4
26Q1
26Q2
26Q3

Available U.S.-primary Prism records matching finance, fintech. Metadata counts can overlap; coverage volume and tone are not measures of industry output.

Recurring Prism themes

campaign finance reform efforts
12,431
political action committees (pacs)
10,711
campaign fundraising strategies
10,574
political fundraising mechanisms
6,403
financial technology (fintech) innovations
6,138
election integrity and voting rights
4,674

Metadata occurrences; one record can contribute more than one theme.

Frequent industry keywords

trade finance 3,435campaign finance criticisms 3,187athletic department finances 2,978film finance 2,677rate-and-term refinance 2,413film investor 2,308sports program funding 2,104mortgage rate locks 1,931

Counts cover the matched industry corpus, not the broader company-news totals above.

Curated signal map

Opportunity and caution, side by side

Evidence prompts—not probabilities.

Opportunity · market driver

financial services

14 forecast sources

A recurring driver in the extracted market evidence provides a measurable research thread for the sector.

Prism /special_extraction market-growth card
Opportunity · demand

campaign finance reform efforts

12,431 matched theme records

The largest current Prism news theme shows where sector attention and reported activity are concentrating.

Prism U.S. news metadata
Opportunity · innovation

Innovation and product activity

10,573 matched news records

Technology, product and R&D metadata provide an auditable view of the sector's innovation conversation.

Unique news records matching the curated innovation rule
Caution · market restraint

Stringent government regulations

7,128 macro/risk records

The extracted restraint and the measured macro-news pulse belong in the downside research frame.

Prism market-growth restraint plus U.S. news metadata
Caution · news pulse

Coverage growth can reverse

+10.7% news volume

The latest 12 months contain 22,916 matched records versus 20,708 in the previous window.

Available Prism coverage through 2026-05-05
Caution · sentiment

Classified tone is not demand

61.4% positive · +15.8pp

Machine-classified news tone is useful context, but it is not revenue, output or a return forecast.

Eight-quarter Prism sentiment series

Opportunity and caution cards are curated research prompts grounded in the counts shown; they are not probabilities, recommendations or forecasts. News coverage runs 2024-01-01–2026-05-05; the latest quarter may be partial.

Explore the broader U.S. industrial landscape →
08 · Scope and sources

How to read this snapshot

Basket and ranking

Five U.S.-listed issuers classified under SEC SIC 6199 (Finance Services), selected as the first five names that pass all live publication gates from the latest filing revenue candidate pool ranked 16–23. Every candidate has complete cached readiness evidence. This is a research cohort, not a recommendation.

Companies are ordered by the Fliar BI Prism readiness score used by the Prism Finance USA source pack. The score is a research signal, not a recommendation.

Evidence used

  • Official annual filingsFY revenue history and latest profitability
  • U.S. exchange market snapshotDated price, 52-week range, P/E, market capitalisation and monthly-close return
  • Fliar BI PrismReadiness, company and industry news, community context and U.S.-scope patent records
  • Prism market-growth extractionDated third-party Finance Services Industry in USA market benchmark with source-count, geography and confidence context
Important: Research and educational information only. Not investment advice, a recommendation, or a live-price service. Market figures are dated as of 31 August 2026.
09 · Final derived analysis

Conclusions, comparisons, anomalies, explanations and decisions

A final evidence-linked synthesis of the metrics already displayed above. Every named company opens its actual Companies Radar profile.

Conclusions
Comparisons
Anomalies

Helius Medical has the widest attention-readiness rank gap

It ranks #1 by measured news attention (98.4%) and #4 by Prism readiness. The gap is a review flag, not evidence that either measure is wrong.

TeraWulf shows a price-operating divergence to inspect

Its displayed filing-revenue change is +744.0% while its available monthly-close return is -46.7%. The signs differ, but the two measures cover different windows and do not establish causality.

Explanations

Attention measures coverage volume, not quality

Helius Medical's 98.4% share says it appears most often in the matched Prism corpus. It does not score whether that coverage is favourable or whether the company is investable.

Different windows explain why signals can disagree

Revenue comes from the printed filing periods, price paths use the dated monthly-close windows, and Prism signals use their stated event windows. No causal attribution is made across them.

Research decisions

Verify the readiness leader in Companies Radar

Open TeraWulf's company profile and inspect the underlying management, market-activity, innovation and risk evidence before relying on the 53/100 score.

Stress-test the largest divergence before forming a view

Compare TeraWulf's profile with TeraWulf's profile, then reconcile the displayed filing and price windows. This is a next-research action, not a buy or sell decision.

Method boundary: These are deterministic comparisons of the displayed snapshot fields. They flag relationships for further research, do not establish causality and are not investment recommendations.
Coming soon